United States Second Circuit

Dismissal of plaintiff's Antitrust claims, alleging that a competing manufacturer and its supplier conspired to restrain trade and monopolize the supply and retail markets of generic warfarin sodium, is reversed where plaintiff's evidence provides a prima facie case of a section 1 Sherman Act violation.

Appellate Information

• Argued 12/04/2003
• Decided 10/18/2004
• Published 10/18/2004

Judges

• CARDAMONE, Circuit Judge:, Before:  CARDAMONE, SACK, and JOHN R. GIBSON , Circuit Judges.

Court

• United States Second Circuit

Counsel

• For Appellant:
  
• Wayne A. Cross, White & Case, New York, New York (Michael J. Gallagher, Brendan G. Woodard, White & Case LLP, New York, New York;  Frederick R. Dettmer, Law Office of Frederick R. Dettmer, New York, New York;  David S. Preminger, Rosen, Preminger & Bloom, New York, New York, of counsel), for Plaintiff-Appellant Geneva Pharmaceuticals Technology Corp., Louis M. Solomon, New York, New York (Harry Frischer, Colin A. Underwood, Jennifer R. Scullion, Daniel J. Rothstein, Proskauer Rose LLP, New York, New York, of counsel), for Plaintiff-Appellant Apothecon, Inc.


• For Appellees:
  
• Michael J. Gaertner, Chicago, Illinois (David G. Greene, Lord, Bissell & Brook, Chicago, Illinois, of counsel), for Defendants-Appellees Brantford Chemicals Inc., Bernard C. Sherman, Apotex Holdings Inc., Apotex Inc., Sherman Delaware, Inc., Kurt L. Schultz, New York, New York (Alan B. Howard, Winston & Strawn, New York, New York, of counsel), for Defendant-Appellee Barr Laboratories, Inc.